Medications for Precursor Tcell Lymphoblastic Leukemialymphoma

13 results
Bamboo US BidCo LLC
Usage: Cyclophosphamide is indicated for treating various malignant diseases including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy is ineffective or intolerable.
Dr. Reddy's Laboratories Inc.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and those with advanced Ph+ CML or Ph+ acute lymphoblastic leukemia (ALL) who are resistant or intolerant to prior therapy. They are also approved for pediatric patients with Ph+ CML and newly diagnosed Ph+ ALL.
Biocon Pharma Inc.
Usage: Dasatinib is indicated for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase, Ph+ CML with resistance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). It is also indicated for pediatric patients aged 1 and older with Ph+ CML and newly diagnosed Ph+ ALL.
Prasco Laboratories
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML), Ph+ CML with resistance/intolerance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). They are also indicated for pediatric patients (≥1 year) with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.
Fresenius Kabi USA, LLC
Usage: Doxorubicin Hydrochloride Injection is indicated for treating various cancers, including leukemias, Wilms' tumor, neuroblastoma, sarcomas, and several carcinomas. It is also used as adjuvant therapy for women with axillary lymph node involvement post-primary breast cancer resection.
Shantou Eelhoe Daily Chemical Technology Co., Ltd.
Usage: The section you provided does not contain any specific information or text regarding the drug's indications and usages. Please provide the relevant details or context about the drug for me to summarize its indications and usages effectively.
Partner Therapeutics, Inc.
Usage: LEUKINE is indicated for various uses, including accelerating neutrophil recovery after acute myeloid leukemia chemotherapy and autologous/allogeneic transplantations, mobilizing hematopoietic progenitor cells, treating delayed neutrophil recovery, and increasing survival in patients exposed to myelosuppressive radiation doses.
XGen Pharmaceuticals DJB, Inc.
Usage: Nelarabine injection is indicated for treating T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adults and children aged 1 year and older, specifically when the disease has not responded to or has relapsed after at least two chemotherapy regimens.
Zydus Pharmaceuticals USA Inc.
Usage: Nelarabine Injection is indicated for treating T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adults and pediatric patients aged 1 year and older who have not responded to or have relapsed after at least two chemotherapy regimens.
Nexus Pharmaceuticals Inc
Usage: Nelarabine Injection is indicated for treating T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adults and pediatric patients aged 1 year and older, specifically for those whose disease has not responded to or has relapsed after at least two chemotherapy regimens.